Table 2.
Model | Main components | Advantages | Limitations | Time and Cost* |
---|---|---|---|---|
Xenograft (cell line) | Immortalized human tumor cell lines transplanted into immunodeficient host (mouse) | Numerous established and well-annotated cell lines | Immunodeficient host | 2–4 wk, $ |
Representation from various human tumor types | Subcutaneous location may not allow cultivation of key tissue-specific stromal infiltrate | |||
Features of tumor microenvironment, including stromal and vascular cells, incorporated within tumor | Cross-species divide; stromal components are mouse, whereas tumor cells are human | |||
Tumors are easily and precisely measured | Limited or no genetic heterogeneity present within tumor | |||
Xenograft (patient-derived) | Human tumor explant propagated in immunodeficient host (mouse) | Heterogeneity and genetic diversity within tumors | Immunodeficient host | 8–24 wk†, $$$ |
Representation from various human tumor types | Subcutaneous location may not allow cultivation of key tissue-specific stromal infiltrate | |||
Features of tumor microenvironment, including stromal and vascular cells, incorporated within tumor | Surgical implantation required | |||
Tumors are easily and precisely measured | Cross-species divide; stromal components are mouse, whereas tumor cells are human | |||
Genetic and phenotypic drift with passage | ||||
Syngeneic | Immortalized mouse tumor cell line allografted into immunocompetent host (mouse) | Presence of intact immune system | Limited number of established cell lines, which are poorly annotated | 2–4 wk, $ |
Features of tumor microenvironment, including stromal and vascular cells, incorporated within tumor | Strong immunogenicity of some lines promotes spontaneous regression | |||
All cell types within tumor are of mouse origin | Rapid growth rate of many lines limits use in longer-term studies | |||
Tumors are easily and precisely measured | ||||
GEMMs | Genetic modification that permits induced or spontaneous tumor development | Tumors develop in tissue of origin | Limited genetic mosaicism and heterogeneity of tumors | 12–24 wk†, $$ |
Presence of intact immune system | Technical hurdlesfor monitoring tumor response in internal organs | |||
All cell types within tumor are of mouse origin | Low throughput and high investment | |||
Features of tumor microenvironment, including stromal and vascular cells, and immune system components |
=low
=low
=intermediate cost
=high cost.
Up to 1 y to observe metastases.
Adapted with permission of (21).